Behavior and knowledge survey to assess the effectiveness of educational materials in patients treated with AUBAGIO® (teriflunomide) (cross-sectional survey)

First published 30/05/2020

Last updated 14/03/2024

EU PAS number:

EUPAS31883

Study

Finalised

Documents

Study protocol

Initial protocol

TERIFC09617_Wave 1 - protocol patient - Aubagio

English (132.23 KB - PDF) View document

Updated protocol

TERIFC09617_Wave 2 - protocol patient - Aubagio

First published: 22/02/2024

English (314.35 KB - PDF) View document

Study results

Aubagio Patients Wave 1 and 2 combined report-Final

English (534.79 KB - PDF) View document

Study report

Other information

Secondary tabs